Clinical Report: Assessment of Sleep Quality in Reproductive-Aged Women in Ethiopia
Overview
This systematic review and meta-analysis reveals that nearly half of Ethiopian women of reproductive age experience poor sleep quality, with a prevalence rate of 49.17%. Key contributing factors include intimate partner violence, depression, and unplanned pregnancies.
Background
Quality sleep is crucial for women's health, particularly during reproductive years, as it impacts both physical and mental well-being. In Ethiopia, socio-economic and cultural factors exacerbate sleep issues, yet data on this demographic remain limited. Understanding sleep quality and its determinants is essential for developing targeted interventions to improve health outcomes for women and their families.
Data Highlights
Factor
Odds Ratio (OR)
Intimate Partner Violence
3.24
Depression
3.37
Unplanned Pregnancy
2.71
Multigravidity
2.61
Substance Use
2.24
Key Findings
Pooled prevalence of poor sleep quality among Ethiopian women of reproductive age is 49.17%.
Intimate partner violence is a significant predictor of poor sleep quality (OR: 3.24).
Depression is associated with an increased risk of poor sleep quality (OR: 3.37).
Unplanned pregnancies contribute to poor sleep quality (OR: 2.71).
Substance use history is linked to poor sleep quality (OR: 2.24).
Multigravidity also increases the likelihood of poor sleep quality (OR: 2.61).
Clinical Implications
Healthcare providers should prioritize screening for sleep quality in reproductive-aged women, particularly those experiencing intimate partner violence, depression, or unplanned pregnancies. Implementing targeted interventions may improve sleep health and overall well-being in this population.
Conclusion
The findings underscore the urgent need for interventions addressing sleep quality among Ethiopian women of reproductive age. Addressing the identified risk factors can significantly enhance maternal and reproductive health outcomes.
Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
